13 Results for "

covalently closed circular DNA

" in MedChemExpress (MCE) Product Catalog:
Products (13)

13 Results for "covalently closed circular DNA" in MCE Product Catalog:

2
2 Cited Publications
Cat. No.: HY-109195
CAS No.: 2090064-66-5
Purity:  99.73%
Synonyms: ABI-H0731
Target:  

HBV

Research Areas:  

Infection Inflammation/Immunology

Vebicorvir (ABI-H0731) is a first-generation hepatitis B virus (HBV) core protein inhibitor. Vebicorvir (ABI-H0731) suppresses covalently closed circular DNA (cccDNA) formation in two de novo infection models with EC50s from 1.84 μM to 7.3 μM .
loading...
    loading...
Cat. No.: HY-148560A
CAS No.: 2413192-49-9
Purity:  99.71%
Target:  

HBV DNA/RNA Synthesis

Research Areas:  

Infection

trans-ccc_R08 (Compound 1-B) is a cccDNA inhibitor with anti-HBV activity, with an IC50 of 0.14 μM for HBeAg and an IC50 of 0.08 μM for HBsAg in in vitro assays. trans-ccc_R08 inhibits covalently closed circular DNA (cccDNA). trans-ccc_R08 is applicable to research related to hepatitis B virus infection .
loading...
    loading...
Cat. No.: HY-148348
CAS No.: 2445597-31-7
Purity:  99.13%
Target:  

HBV

Research Areas:  

Infection

AB-836 is an orally active HBV capsid inhibitor. AB-836 inhibits viral replication by interacting with HBV core protein. AB-836 can be used in research related to chronic hepatitis B .
loading...
    loading...
Cat. No.: HY-148560B
CAS No.: 2413192-48-8
Purity:  99.61%
Target:  

HBV

Research Areas:  

Infection

cis-ccc_R08 (compound 1) is a flavonoid derivative that can be used in the study of hepatitis B virus (HBV) infection. cis-ccc_R08 is a cccDNA (covalently closed circular DNA) inhibitor .
loading...
    loading...
Cat. No.: HY-16680
CAS No.: 840529-13-7
Synonyms: Helioxanthin analogue 8-1
Target:  

HBV

Research Areas:  

Infection

Helioxanthin 8-1(Helioxanthin analogue 8-1) is an anti-HBV agent. Helioxanthin 8-1 exhibits anti-hepatitis B virus activity in both in vitro human hepatitis B virus models and animal models. Helioxanthin 8-1 inhibits the synthesis of duck hepatitis B virus (DHBV) DNA, covalently closed circular DNA, RNA and proteins, thereby blocking DHBV replication. Helioxanthin 8-1 shows higher cytotoxicity in virus-induced cells than in non-induced cells. Helioxanthin 8-1 can be used in studies related to hepatitis B virus infection .
loading...
    loading...
Cat. No.: HY-148781
CAS No.: 2413192-92-2
Target:  

HBV

Research Areas:  

Infection

HBV-IN-30 (ex44), a flavone derivative, is a potent covalently closed circular DNA (cccDNA) inhibitor. cccDNA serves as the template for viral RNA transcription and subsequent viral DNA generation. HBV-IN-30 has the potential for the research of HBV infection .
loading...
    loading...
Cat. No.: HY-148783
CAS No.: 2413193-04-9
Target:  

HBV

Research Areas:  

Infection

HBV-IN-32 is a potent cccDNA (covalently closed circular DNA) inhibitor. HBV-IN-32 shows anti-HBV activity with an IC50 value of 0.14 µM for HBsAg. HBV-IN-32 inhibits cell growth .
loading...
    loading...
Cat. No.: HY-144045
CAS No.: 2712529-19-4
Target:  

HBV DNA/RNA Synthesis

Research Areas:  

Infection

HBV-IN-14 is a potent inhibitor of covalently closed circular DNA (cccDNA). cccDNA serves as the template for viral RNA transcription and subsequent viral DNA generation. HBV-IN-14 is a pyridinopyrimidinones compound. HBV-IN-14 has the potential for the research of HBV infection (extracted from patent WO2021190502A1, compound 5) .
loading...
    loading...
Cat. No.: HY-144046
CAS No.: 2413192-50-2
Target:  

HBV DNA/RNA Synthesis

Research Areas:  

Infection

HBV-IN-15 is a potent inhibitor of covalently closed circular DNA (cccDNA). cccDNA serves as the template for viral RNA transcription and subsequent viral DNA generation. HBV-IN-15 is a flavone derivative. HBV-IN-16 has the potential for the research of HBV infection (extracted from patent WO2020052774A1, compound 2) .
loading...
    loading...
Cat. No.: HY-144047
CAS No.: 2355225-38-4
Target:  

HBV DNA/RNA Synthesis

Research Areas:  

Infection

HBV-IN-16 is a potent inhibitor of covalently closed circular DNA (cccDNA). cccDNA serves as the template for viral RNA transcription and subsequent viral DNA generation. HBV-IN-16 is a quinoline derivative. HBV-IN-16 has the potential for the research of HBV infection (extracted from patent WO2019121357A1, compound 1) .
loading...
    loading...
Cat. No.: HY-148780
CAS No.: 2413192-59-1
Target:  

HBV

Research Areas:  

Infection

HBV-IN-29 (ex8), a flavone derivative, is a potent covalently closed circular DNA (cccDNA) inhibitor. cccDNA serves as the template for viral RNA transcription and subsequent viral DNA generation. HBV-IN-29 has the potential for the research of HBV infection .
loading...
    loading...
Cat. No.: HY-148782
CAS No.: 2413192-95-5
Target:  

HBV

Research Areas:  

Infection

HBV-IN-31 is a potent cccDNA (covalently closed circular DNA) inhibitor. HBV-IN-31 shows anti-HBV activity with an IC50 value of 0.13 µM for HBsAg. HBV-IN-31 inhibits cell growth .
loading...
    loading...
Cat. No.: HY-109195R
CAS No.: 2090064-66-5
Synonyms: ABI-H0731 (Standard)
Target:  

Reference Standards HBV

Research Areas:  

Infection Inflammation/Immunology

Vebicorvir (Standard) is the analytical standard of Vebicorvir (HY-109195). This product is intended for research and analytical applications. Vebicorvir (ABI-H0731) is a first-generation hepatitis B virus (HBV) core protein inhibitor. Vebicorvir (ABI-H0731) suppresses covalently closed circular DNA (cccDNA) formation in two de novo infection models with EC50s from 1.84 μM to 7.3 μM .
loading...
    loading...
  • 1